HAINES v. TAKEDA PHARMACUETICALS USA, INC.

CourtDistrict Court, D. New Jersey
DecidedAugust 31, 2023
Docket3:20-cv-04336
StatusUnknown

This text of HAINES v. TAKEDA PHARMACUETICALS USA, INC. (HAINES v. TAKEDA PHARMACUETICALS USA, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HAINES v. TAKEDA PHARMACUETICALS USA, INC., (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MICHAEL HAINES, Plaintiff, Civil Action No. 20-04336 (GC) (JBD)

v. OPINION

TAKEDA PHARMACEUTICALS USA, INC., et al., Defendants. CASTNER, District Judge This matter comes before the Court upon Defendants Takeda Pharmaceuticals USA, Inc. (“Takeda”) and Serina Fischer’s motion for summary judgment, pursuant to Federal Rule of Civil Procedure (“Rule”) 56. (ECF No. 27.) Plaintiff Michael Haines opposed (ECF No. 31), and Defendants replied (ECF No. 33). The Court has carefully considered the parties’ submissions and decides the motion without oral argument pursuant to Rule 78(b) and Local Civil Rule 78.1(b). For the reasons set forth below, and other good cause shown, Defendants’ motion is GRANTED IN PART and DENIED IN PART. I. BACKGROUND1 A. FACTUAL BACKGROUND2 The Court recites only the uncontested facts necessary to contextualize the present motion.3 In July 2018, Plaintiff began his employment with Takeda as a Regional Business Director. (DSUMF & PRDSUMF ¶ 5.) Plaintiff was the only Black Regional Business Director serving

under his supervisor in the Great Lakes territory. (PSUMF & DRPSUMF ¶ 2.) As his position was a field-based sales position, Plaintiff lived and operated out of New Jersey while serving the Great Lakes territory. (DSUMF & PRDSUMF ¶ 6.) Plaintiff’s offer letter for this initial position with Takeda (the “First Offer Letter”) included a one-time signing bonus of $65,000 (the “Signing Bonus”). (DSUMF & PRDSUMF ¶ 9; Defs.’ Ex. 16, First Offer Letter, ECF No. 27-5 at 10.) By the terms of the First Offer Letter, the Signing Bonus had to be repaid to Takeda if Plaintiff’s employment ended within two years of his start date for a reason other than a company restructuring or reduction in workforce. (ECF No. 27-5 at 10.) In 2019, Plaintiff saw Fischer at a social function in Los Angeles. (DSUMF & PRDSUMF

¶ 15.) Fischer, a Vice President of Marketing at Takeda, was one of the people who interviewed Plaintiff for his initial hiring at Takeda. (DSUMF & PRDSUMF ¶ 8; PSUMF & DRPSUMF ¶

1 On a motion for summary judgment, the Court “draw[s] all reasonable inferences from the underlying facts in the light most favorable to the nonmoving party.” Jaffal v. Dir. Newark New Jersey Field Off. Immigr. & Customs Enf’t, 23 F.4th 275, 281 (3d Cir. 2022) (quoting Bryan v. United States, 913 F.3d 356, 361 n.10 (3d Cir. 2019)).

2 Defendants’ Rule 56.1 Statement of Undisputed Material Facts (“DSUMF”) is at ECF No. 27-2; Plaintiff’s Response to Defendants’ Statement of Undisputed Material Facts (“PRDSUMF”) is at ECF No. 31 at 19-31; Plaintiff’s Statement of Undisputed Material Facts (“PSUMF”) is at ECF No. 31 at 1-19; and Defendants’ Response to Plaintiff’s Statement of Undisputed Material Facts (“DRPSUMF”) is at ECF No. 33-1.

3 All other relevant or material facts are contested and will be recited where applicable in the Court’s analysis below. 10.) Plaintiff expressed to Fischer a desire to obtain marketing experience and inquired as to whether she had any openings on her team. (DSUMF & PRDSUMF ¶ 16.) Sometime thereafter, although Plaintiff had no marketing experience in the industry, he was offered an interview for a marketing role on Fischer’s team. (DSUMF & PRDSUMF ¶ 17.) In May 2019, Takeda offered Plaintiff the position of Associate Director within the Behavioral Disorders, Health Care

Professionals (“HCP”) Marketing Division. (DSUMF & PRDSUMF ¶ 18.) In his new role, Plaintiff reported to Erik Cline. (DSUMF & PRDSUMF ¶ 19.) Cline, in turn, reported to Fischer. (Id.) Plaintiff’s new role was conditioned upon his relocation to the Boston area. (DSUMF & PRDSUMF ¶¶ 20-21; PSUMF & DRPSUMF ¶ 5.) The relocation requirement was memorialized in a May 22, 2019 Offer of Employment Letter (the “Second Offer Letter”), signed by Plaintiff. (Defs.’ Ex. 8, Second Offer Letter, ECF No. 27-4 at 63-66.) The Second Offer Letter promised Plaintiff two types of benefits to support his relocation to the Boston area: (1) relocation support; and (2) a one-time bonus payment of $50,000 “to further assist [Plaintiff] in [his] transition to the

Boston area” (the “Transfer Bonus”). (DSUMF & PRDSUMF ¶¶ 23-24; ECF No. 27-4 at 65.) By the terms of the Second Offer Letter, the Transfer Bonus was only to be paid “within 30 days of a signed contract for the purchase or lease of a home in the Boston area.” (ECF No. 27-4 at 65.) On May 24, 2019, Plaintiff was informed by a relocation vendor that Plaintiff’s relocation support would not be processed until after his move to Boston was complete. (DSUMF & PRDSUMF ¶ 27.) On August 28, 2019, Plaintiff emailed Human Resources Business Partner Jane Runde and inquired further about when the Transfer Bonus would be paid. (DSUMF & PRDSUMF ¶ 31.) The email chain read as follows: Hello [Runde] – [I] hope all is well. We spoke a few months ago when [I] was transitioning into my position in marketing. I was hoping you could answer a question for me. According to my relocation to Boston [I] was offered the $50k [Transfer Bonus]. Can you let me know the timing for that payment. I’ve been working in Lexington[, Massachusetts] for 3 months now.

[(Id.)]

Runde replied:

Once you physically move and give me your new address you will receive your transfer bonus. Hope that helps.

Plaintiff then asked:

Are there ever exceptions where it . . . can be given pre[-]move? For example[, I] [m]ay continue to commute or [I] may just get an apartment and not move the whole family – just myself. How would that work?”

No exceptions – once you get your apartment you just need to let me know.

Thereafter, Plaintiff began looking for an apartment. (See DSUMF & PRDSUMF ¶ 35.) Plaintiff expressed to a landlord in Boston, Eric Lindsey, that Plaintiff needed a “crash pad or temporary lease that was flexible . . . .” (DSUMF & PRDSUMF ¶ 35.) Following their conversation, Lindsey sent Plaintiff an email via DocuSign that read “Please DocuSign Tenancy at Will.” (DSUMF & PRDSUMF ¶ 36.) When Plaintiff accessed the enclosed document, he saw that Lindsey had not signed it. (DSUMF & PRDSUMF ¶ 37.) Plaintiff signed the document, and then received a second email from Lindsey stating that all parties had completed the rental lease. (DSUMF & PRDSUMF ¶ 38.) The lease itself was for an apartment near Boston, with a start date of October 15, 2019, which Plaintiff agreed to pay $2,200 a month to lease. (DSUMF & PRDSUMF ¶ 40.) The lease, however, does not specify any unit to be leased in the building and Plaintiff testified that he never spoke with Lindsey about leasing any unit in particular. (DSUMF & PRDSUMF ¶ 41.) Plaintiff

further testified that although he signed a tenancy-at-will, allowing him a right to lease an apartment from Lindsey, he never actually saw or leased the apartment. (DSUMF & PRDSUMF ¶¶ 42-43.) Plaintiff also testified that he never paid Lindsey any money to lease the apartment. (DSUMF & PRDSUMF ¶ 44.) Plaintiff stated that he did not want to lease the apartment from Lindsey at that time because he was exploring various financial arrangements like whether his wife’s employer would pay for the apartment. (DSUMF & PRDSUMF ¶ 45.) After communicating with Lindsey and signing the above discussed tenancy-at-will lease, on October 6, 2019, Plaintiff emailed Runde stating that he had an apartment, and provided Runde with an address. (DSUMF & PRDSUMF ¶ 32.) Plaintiff did not provide her with a signed lease.

(DSUMF & PRDSUMF ¶ 33.) Runde thanked him, congratulated him on the new apartment, and told Plaintiff that she would submit the Transfer Bonus for processing.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Mylan Inc. v. Smithkline Beecham Corp.
723 F.3d 413 (Third Circuit, 2013)
Kalogeras v. 239 Broad Avenue, L.L.C.
997 A.2d 943 (Supreme Court of New Jersey, 2010)
Zive v. Stanley Roberts, Inc.
867 A.2d 1133 (Supreme Court of New Jersey, 2005)
Clowes v. Terminix International, Inc.
538 A.2d 794 (Supreme Court of New Jersey, 1988)
Jason v. Showboat Hotel & Casino
747 A.2d 802 (New Jersey Superior Court App Division, 2000)
Maniscalco v. Brother International Corp.
627 F. Supp. 2d 494 (D. New Jersey, 2009)
Williams v. PEMBERTON TP. SCHOOLS
733 A.2d 571 (New Jersey Superior Court App Division, 1999)
Tarr v. Ciasulli
853 A.2d 921 (Supreme Court of New Jersey, 2004)
Wade v. Kessler Institute
798 A.2d 1251 (Supreme Court of New Jersey, 2002)
Wilson v. Amerada Hess Corp.
773 A.2d 1121 (Supreme Court of New Jersey, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
HAINES v. TAKEDA PHARMACUETICALS USA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/haines-v-takeda-pharmacueticals-usa-inc-njd-2023.